OA18.05LB | Multivalent antigen presentation increases the antibody binding breadth and neutralizing potency upon the immunization with a self-assembling HIV env vaccine | Oral Abstract Session | Novel vaccine and other prevention approaches |
OA19.01 | Impact of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomized placebo-controlled trial | Oral Abstract Session | Microbiome & STI: impact on prevention |
OA19.02 | Construction of a comprehensive bacterial genome catalogue for the female genital tract identifies hundreds of new species | Oral Abstract Session | Microbiome & STI: impact on prevention |
OA19.03 | Transcriptional analysis of cervical cell populations reveals inflammatory signatures and differential epithelial keratinization associated with Depo-Provera use | Oral Abstract Session | Mucosal immunity |
OA19.04LB | Silk fibroin as a mucosal delivery vehicle for Griffithsin and antiviral compounds: effective protection of macaques and high acceptance among user groups | Oral Abstract Session | Delivery technologies: novel approaches, formulation and multi-purpose |
OA19.05LB | Pharmacokinetic and pharmacodynamic study of tenofovir and tenofovir alafenamide for PrEP in foreskin tissue | Oral Abstract Session | Pharmacology/PK and PD studies |
OA20.01 | Alternative T cell effector functions are linked to humoral responses to HIV infection | Oral Abstract Session | Cellular immunity |
OA20.02 | HIV-resistant dual CD28/4-1BB costimulated CAR T cells mitigate HIV pathogenesis in humanized mice | Oral Abstract Session | Cellular immunity |
OA20.03 | Immune perturbation is more profound in newborn than in infant macaques during acute SHIV infection | Oral Abstract Session | Preclinical studies for HIV prevention |
OA20.04 | Tissue-resident memory CD4+ T cells in ectocervical versus endocervical specimens | Oral Abstract Session | Mucosal immunity |